Author:
Singh Zeba N.,Gulley Margaret L.
Reference125 articles.
1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissue (IARC WHO classification of tumours). 4th ed. Lyon, France: IARC press; 2008.
2. O’Donnell MR, Abboud CN, Altman J, Appelbaum FR, Arber DA, Coutre SE, et al. NCCN clinical practice guidelines in oncology TM. Acute Myeloid Leukemia. (2011). http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
3. Vorsanova SG, Yurov YB, Iourov IY. Human interphase chromosomes: a review of available molecular cytogenetic technologies. Mol Cytogenet. 2010;3:1–15.
4. Harrison CJ, Haas O, Harbott J, Biondi A, Stanulla M, Trka J, et al. Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: recommendations from the biology and diagnosis committee of the international Berlin-Frankfurt-Munster study group. Br J Haematol. 2010;151(2):132–42.
5. Hasle H, Alonzo TA, Auvrignon A, Behar C, Chang M, Creutzig U, et al. Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. Blood. 2007;109(11):4641–7.